IIUM Repository

Mohd Hafiz Abdul Aziz

Pharmacy Practice

Profile Picture

Latest Additions

  1. Koulenti, Despoina and Song, Andrew and Ellingboe, Aaron and Abdul-Aziz, Mohd Hafiz and Harris, Patrick and Gavey, Emile S. and Lipman, Jeffrey (2019) Infections by multidrug-resistant Gram-negative bacteria: what's new in our arsenal and what's in the pipeline? International Journal of Antimicrobial Agents, 53 (3). pp. 211-224. ISSN 0924-8579 E-ISSN 1872-7913
  2. Cheng, Vesa and Abdul-Aziz, Mohd Hafiz and Roberts, Jason A. and Shekar, Kiran (2019) Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients. Expert Opinion on Drug Metabolism and Toxicology, 15 (2). pp. 103-112. ISSN 1742-5255
  3. Cheng, Vesa and Abdul Aziz, Mohd. Hafiz and Roberts, Jason A. and Shekar, Kiran (2018) Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. Journal of Thoracic Disease, 10. S629-S641. ISSN 2072-1439 E-ISSN 2077-6624
  4. Abdul Aziz, Mohd. Hafiz and Lipman, Jeffrey and Roberts, Jason A. (2017) Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections. Critical Care, 21 (283). pp. 1-3. ISSN 1364-8535
  5. Abdul Aziz, Mohd. Hafiz (2017) Antibiotics and ECMO. In: Chinese Critical Care Congress (CCCC), 15th-17th September 2017, Qingdao, China. (Unpublished)
  6. Abdul Aziz, Mohd. Hafiz (2017) Using PK/PD to optimize antibiotic dosing in critically ill patients. In: Chinese Critical Care Conference (CCCC), 15th-17th September 2017, Qingdao, China. (Unpublished)
  7. Rhodes, Nathaniel J. and Liu, Jiajun and O'Donnell, J. Nicholas and Dulhunty, Joel M. and Abdul Aziz, Mohd. Hafiz and Berko, Patsy Y. and Nadler, Barbara and Lipman, Jeffrey and Roberts, Jason A. (2018) Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis. Critical Care Medicine, 46 (2). pp. 236-243. ISSN 0090-3493 E-ISSN 1530-0293
  8. Sinnah, Fabrice and Shekar, Kiran and Abdul Aziz, Mohd. Hafiz and Buscher, Hergen and Diab, Sara and Fisquet, Stephanie and Fung, Yoke and McDonald, Charles and Reynolds, Claire and Rudham, Sam and Wallis, Steven C. and Welch, Susan and Xie, Jiao and Fraser, John and Roberts, Jason A. (2017) Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation. Critical Care and Resuscitation, 19 (Suppl 1). pp. 8-14. ISSN 1441-2772
  9. Abdul Aziz, Mohd. Hafiz and Shekar, Kiran and Roberts, Jason A. (2018) Antibiotic dosing during extracorporeal membrane oxygenation. In: Antibiotic pharmacokinetic/pharmacodynamic considerations in the critically III. Springer, Singapore, pp. 151-171. ISBN 9789811053351
  10. Sulaiman, Helmi and Abdul Aziz, Mohd. Hafiz and Roberts, Jason A. (2017) Pharmacokinetic/pharmacodynamics-optimized antimicrobial therapy in patients with hospital-acquired pneumonia/ventilator-associated pneumonia. Seminars in Respiratory and Critical Care Medicine, 38 (3). pp. 271-286. ISSN 1069-3424
  11. Abdul Aziz, Mohd. Hafiz (2016) Optimizing antibiotic therapy for Gram-negative infections. In: University Malaya Medical Centre (UMMC) Infectious Diseases Workshop: Antibiotic Master Class 3.0, University Malaya Medical Centre (UMMC), Kuala Lumpur. (Unpublished)
  12. Abdul Aziz, Mohd. Hafiz and Lipman, Jeffrey and Roberts, Jason A. (2017) Antibiotic dosing for multidrug-resistant pathogen pneumonia. Current Opinion in Infectious Diseases, 30 (2). pp. 231-239. ISSN 0951-7375 E-ISSN 1473-6527
  13. Osthoff, Michael and Siegemund, Martin and Balestra, Gianmarco and Abdul Aziz, Mohd. Hafiz and Roberts, Jason A. (2016) Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Swiss Medical Weekly, 146. w14368-1-w14368-13. ISSN 1424-3997 E-ISSN 1424-3997
  14. Delgado-Valverde, Mercedes and Torres, Eva and Valiente-Mendez, Adoracion and Almirante, Benito and Gomez-Zorrilla, Silvia and Borrell, Nuria and Corzo, Juan E. and Gurgui, Mercedes and Almela, Manuel and Garcia-Alvarez, Lara and Fontecoba-Sanchez, Maria Cruz and Martinez-Martinez, Luis and Canton, Rafael and Praena, Julia and Causse, Manuel and Gutierrez-Gutierrez, Belen and Roberts, Jason A. and Farkas, Andras and Pascual, Alvaro and Rodriguez-Bano, Jesus and de Cueto, Marina and Planes Reig, Ana Maria and Quintano, Fe Tubau and Pena, Carmen and Otalora, M. Elvira and de Alegria, Carlos Ruiz and Morosini, M. Isabel and Lepe, Jose Antonio and Cisneros, Jose Miguel and Morey, Shawna and Abdul Aziz, Mohd. Hafiz (2016) Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. Journal of Antimicrobial Chemotherapy, 71 (2). pp. 521-530.
  15. Roberts, Jason A. and Abdul Aziz, Mohd. Hafiz and Davis, Joshua S. and Dulhunty, Joel M. and Cotta, Menino O. and Myburgh, John and Bellomo, Rinaldo and Lipman, Jeffrey (2016) Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials. American Journal of Respiratory and Critical Care Medicine, 194 (6). pp. 681-691. ISSN 1073-449X
  16. Abdul Aziz, Mohd. Hafiz and Sulaiman, Helmi and Mat Nor, Mohd Basri and Rai, Vineya and Wong, K. and Hasan, Mohd Shahnaz and Abd. Rahman, Nurul Azrin and Jamal, Janattul-Ain and Wallis, Steven C. and Lipman, Jeffrey and Staatz, Christine E. and Roberts, Jason A. (2016) Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive care medicine. pp. 1-11. ISSN 0342-4642 E-ISSN 1432-1238
  17. Alobaid, Abdulaziz S. and Brinkmann, Alexander and Frey, Otto R. and Roehr, Anka C. and Luque, Sonia and Grau, Santiago and Wong , Gloria and Abdul Aziz, Mohd. Hafiz and Roberts, Michael S. and Lipman, Jeffrey and Roberts, Jason A. (2015) What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients? Journal of Antimicrobial Chemotherapy, 71 (2). pp. 1-7. ISSN 0305-7453
  18. Abdul Aziz, Mohd. Hafiz and Abd. Rahman, Nurul Azrin and Mat Nor, Mohd Basri and Sulaiman, Helmi and Wallis, Steven C. and Lipman, Jeffrey and Roberts, Jason A. and Staatz, Christine E. (2016) Population pharmacokinetics of doripenem in critically ill patients with sepsis in a Malaysian intensive care unit. Antimicrobial agents and chemotherapy, 60 (1). pp. 206-214. ISSN 0066-4804 E-ISSN 1098-6596
  19. Abdul Aziz, Mohd. Hafiz and Sulaiman, Helmi and Mat Nor, Mohd. Basri and Rai, Vineya and Wong, K. and Hasan , Mohd Shahnaz and Wallis, Steven C and Lipman, Jeffrey and Staatz, Christine E. and Roberts, Jason A. (2015) The BLISS study: Beta-Lactam infusion in severe sepsis-randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis in a Malaysian ICU setting. In: Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and 28th International Congress of Chemotherapy (ICC) Meeting (ICAAC/ICC 2015), 17-21 September 2015, San Diego, CA. (Unpublished)
  20. Abdul Aziz, Mohd. Hafiz and Lipman, Jeffrey and Akova, Murat and Bassetti, Matteo and De Waele, Jan J. and Dimopoulos, George and Dulhunty, Joel M. and Kaukonen, Kirsi-Maija and Koulenti, Despoina and Martin, Claude and Montravers, Philippe and Rello, Jordi and Rhodes, Andrew and Starr, Therese and Wallis, Steven C. and Roberts, Jason A. (2015) Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort. Journal of Antimicrobial Chemotherapy. pp. 1-12. ISSN 1460-2091 (O), 0305-7453 (P)

Most Viewed Items

Item titleViews
1Defining antibiotic dosing in lung infections1917
2Continuous beta-lactam infusion in critically ill patients: the clinical evidence1050
3The BLISS study: Beta-Lactam infusion in severe sepsis-randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis in a Malaysian ICU setting1004
4Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU921
5Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development862
6Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions821
7The DALI study: defining antibiotic levels in intensive care unit patients: prolonged infusion of beta-lactam antibiotics in critically ill patients794
8Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 764
9What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?763
10Population pharmacokinetics of doripenem in critically ill patients with sepsis in a Malaysian intensive care unit752
11Plasma & subcutaneous tissue pharmacokinetics of piperacillin in a large cohort of critically ill patients with sepsis679
12Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials649
13Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal637
14Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis595
15Antibiotic dosing during extracorporeal membrane oxygenation590
16Antibiotic dosing for multidrug-resistant pathogen pneumonia535
17Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project.526
18Optimizing antibiotic therapy for Gram-negative infections470
19Pharmacokinetic/pharmacodynamics-optimized antimicrobial therapy in patients with hospital-acquired pneumonia/ventilator-associated pneumonia449
20Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections379
21Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis352
22Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation340
23Antibiotics and ECMO333
24Using PK/PD to optimize antibiotic dosing in critically ill patients.326
25Optimising drug dosing in patients receiving extracorporeal membrane oxygenation205
26Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients106
27Infections by multidrug-resistant Gram-negative bacteria: what's new in our arsenal and what's in the pipeline?28